Purchase Order 75N91021P00086
Award Date 12/15/20
Potential Completion Date 1/8/21
Potential Value $11K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Minneapolis, MN 55413, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Research And Diagnostic Systems, Inc. for $11,500 on August 6, 2020 for custom protein development product. Place of performance is Minneapolis, Minnesota. The order has a firm fixed price structure and an ultimate completion date of November 2, 2020. No set-aside was used.</p>
- This purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Research and Diagnostic Systems, Inc. is valued at $445,214.70 to deliver 89 items including 27 types of recombinant human proteins and 12 small molecule compounds by June 30, 2021. As the sole source provider, Research and Diagnostic Systems will ship the products from its Minneapolis location within 14 days of each order to support the Center's consistent research...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Research And Diagnostic Systems, Inc. for $37,492.75 on March 1, 2020, with ultimate completion by February 28, 2021. The order procures protein measurement using multiplex platforms. Work is performed in Minneapolis, Minnesota. The awardee is a for-profit manufacturer of biological research materials and a subsidiary of Bio-Techne Corporation, competing under open competition with no set-aside.</p>
- <p>The National Institute on Aging awarded a purchase order to Research and Diagnostic Systems, Inc. for custom array service on June 1, 2020, with a ceiling value of $10,200.00 and an ultimate completion date of July 10, 2020. Work is performed in Minneapolis, Minnesota. No set-aside category was used; this was an open competition purchase order using firm fixed price terms.</p>
- Research and Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation, was awarded a Blanket Purchase Agreement (BPA) call valued at $11,340.00 by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health. This fixed-price, redetermination contract was awarded on February 23, 2012, with an ultimate completion date of August 31, 2012, and was performed at the company's Minneapolis, Minnesota location. The...
- Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, was awarded a Blanket Purchase Agreement (BPA) call valued at $3,201.80 by the National Institute of Neurological Disorders and Stroke (NINDS) on February 4, 2013, with an ultimate completion date of August 31, 2013. The contract utilized firm fixed pricing and was not designated as a set-aside purchase, indicating open...
- The NIH Clinical Center awarded a purchase order to Research and Diagnostic Systems, Inc. valued at $9,325.35 on July 16, 2019, with performance completion targeted for July 31, 2019. The order is firm-fixed-price, issued under no set-aside. Place of performance is Bethesda, Maryland. The purchase order procures biological research materials and laboratory supplies—including recombinant proteins, antibodies, ELISA kits, and specialized reagents—from R&D Systems' established product catalog...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,672.20 firm fixed price purchase order to Research And Diagnostic Systems, Inc., doing business as R&D Systems, a division of Bio-Techne Corporation. The contract is for the delivery of recombinant human NT-3 protein to support the agency's research efforts. As the prime contractor, R&D Systems will provide the requested products from its...
- The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed-price BPA call contract worth $17,000 to R&D Systems, Inc., a subsidiary of Bio-Techne Corporation. The contract is for the provision of research and development (R&D) systems, including biological supplies, reagent kits, recombinant proteins, and laboratory instrumentation to support biomedical research, including studies related to COVID-19 and other infectious...
- <p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Research and Diagnostic Systems, Inc. for $11,681.56 on March 3, 2017. The order was firm fixed price with no set-aside. Performance occurred in Minneapolis, Minnesota. The order expired on May 31, 2017 and procured biological research materials and laboratory supplies, including proteins, antibodies, and assay kits for biomedical research support.</p>